SCHEMBL24994737

SCHEMBL24994737

CCOc1ccc(-c2cnc(CC)c(C(=O)OC)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.52
▸ RAB9A P51151 5/20 0.52
▸ MAPT P10636 5/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ ADORA3 P0DMS8 1/20 0.45
▸ SCN2A Q99250 3/20 0.45
▸ SCN10A Q9Y5Y9 3/20 0.45
▸ ALDH1A1 P00352 5/20 0.43
▸ HPGD P15428 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ ALPL P05186 2/20 0.42
▸ THRB P10828 1/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ LMNA P02545 1/20 0.42
▸ PRKDC P78527 1/20 0.41
▸ ATR Q13535 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24993560 0.86 ALDH1A1 (0.54) NPC1RAB9AMAPTKDM4EADORA3
SCHEMBL24993600 0.86 NPC1 (0.53) NPC1RAB9AMAPTKDM4EADORA3
SCHEMBL24993543 0.85 NPC1 (0.52) NPC1RAB9AMAPTKDM4EADORA3
SCHEMBL24994337 0.85 NPC1 (0.52) NPC1RAB9AMAPTKDM4EADORA3
SCHEMBL24993550 0.81 NPC1 (0.52) NPC1RAB9AMAPTKDM4EADORA3
SCHEMBL24993576 0.80 NPC1 (0.50) NPC1RAB9AMAPTKDM4EADORA3
SCHEMBL24994714 0.77 NPC1 (0.46) NPC1RAB9AMAPTKDM4EADORA3
SCHEMBL24994319 0.76 SCN10A (0.64) NPC1RAB9AMAPTKDM4EADORA3
SCHEMBL31547771 0.75 RAB9A (0.57) NPC1RAB9AKDM4EADORA3ALDH1A1
SCHEMBL24993559 0.75 ALDH1A1 (0.53) NPC1RAB9AMAPTKDM4EADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback